Market Cap 233.61M
Revenue (ttm) 70.39M
Net Income (ttm) -43.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -62.47%
Debt to Equity Ratio 0.94
Volume 1,050,900
Avg Vol 1,047,802
Day's Range N/A - N/A
Shares Out 90.90M
Stochastic %K 11%
Beta 2.48
Analysts Strong Sell
Price Target $6.58

Company Profile

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 421 8100
Address:
200 Penobscot Drive, Redwood City, United States
djohndjohn
djohndjohn Jun. 22 at 9:19 PM
$CDXS Stephen G. DillyDally😀, M.B.B.S., Ph.D. received 47,074,970 votes in favor,😁 6,891,598 votes withheld😁, and 20,771,912 broker non-votes. 6,891,598 votes withheld, That's about the same amount of shares that Opaleye(AKA Jimmy)owns. Jimmy don't like DillyDally. I'm begining to feel the same way
0 · Reply
galaxySky
galaxySky Jun. 22 at 8:50 PM
$CDXS surprised this is disconnected from xbi. Macro trends aren't affecting it, sus..
0 · Reply
djohndjohn
djohndjohn Jun. 22 at 4:42 PM
$CDXS Dilly and BoD are a bunch of Bozo's Gave themselves way too many options with an exercise price of $2.48. Basically saying the stock is worth $2.48. Better get off their duff's and add some value for the shareholders
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 19 at 3:13 PM
I believe the writing is on the wall, $MRK completely owning $CDXS IP now makes complete sense!
2 · Reply
Fingerlickengood
Fingerlickengood Jun. 19 at 1:03 PM
$CDXS $MRK "Protillion’s Prot-MaP™ technology and Codexis’ ECO Synthesis® platform represent two complementary frontiers in biotherapeutic engineering: Prot-MaP focuses on ultra-high-throughput, AI-driven protein discovery and optimization, while ECO Synthesis focuses on scalable, green therapeutic RNA manufacturing. Together, they showcase the industry-wide shift toward integrating automated high-throughput biology, AI, and green biocatalysis to overcome traditional drug development bottlenecks. While Protillion’s primary focus is on protein/antibody design (amino acids) and Codexis' ECO platform is generally for RNA/oligonucleotides, the two technologies could intersect if a developer is working on complex conjugate therapies or if Codexis applies its enzyme technology to peptide/protein manufacturing."
4 · Reply
JulesRocketManVern
JulesRocketManVern Jun. 18 at 6:56 PM
$CDXS hit the break out..... Come on!
0 · Reply
Trq2507
Trq2507 Jun. 18 at 5:44 PM
$CDXS takeover @ $9.50
0 · Reply
Kanate123
Kanate123 Jun. 18 at 1:28 PM
$RUM $CDXS bet the ranch a trie lottery ticket
1 · Reply
Kanate123
Kanate123 Jun. 18 at 1:24 PM
$QS also buy Codexis $CDXS a triple from here check out cantor fitzgerald 11 price yesterday
2 · Reply
Kanate123
Kanate123 Jun. 18 at 1:20 PM
$QS this is another good runner, but I also own a ton of codexis .  I took a major position in yesterday Canter raised and reiterates an $11 stock price. This is at least a triple if not more. $CDXS  I bet the ranch big-time
0 · Reply
Latest News on CDXS
Codexis Transcript: AGM 2026

Jun 17, 2026, 12:00 PM EDT - 5 days ago

Codexis Transcript: AGM 2026


Codexis Slides: Corporate presentation

Jun 2, 2026, 7:00 AM EDT - 21 days ago

Codexis Slides: Corporate presentation


Codexis reports Q1 EPS (10c), consensus (10c)

2026-05-07T22:52:18.000Z - 6 weeks ago

Codexis reports Q1 EPS (10c), consensus (10c)


Codexis backs FY26 revenue view $72M-$76M, consensus $74.24M

2026-05-07T22:51:14.000Z - 6 weeks ago

Codexis backs FY26 revenue view $72M-$76M, consensus $74.24M


Codexis Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 6 weeks ago

Codexis Earnings Call Transcript: Q1 2026


Codexis Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 6 weeks ago

Codexis Earnings release: Q1 2026


Codexis Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 6 weeks ago

Codexis Quarterly report: Q1 2026


Codexis Reports First Quarter 2026 Financial Results

May 7, 2026, 4:05 PM EDT - 6 weeks ago

Codexis Reports First Quarter 2026 Financial Results


Codexis to share RNA manufacturing advances at TIDES USA

Apr 29, 2026, 9:00 AM EDT - 7 weeks ago

Codexis to share RNA manufacturing advances at TIDES USA


Codexis Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 7 weeks ago

Codexis Proxy statement: Proxy filing


Codexis Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 7 weeks ago

Codexis Proxy statement: Proxy filing


Codexis Earnings Call Transcript: Q4 2025

Mar 11, 2026, 4:30 PM EDT - 3 months ago

Codexis Earnings Call Transcript: Q4 2025


Codexis Annual report: Q4 2025

Mar 11, 2026, 4:30 PM EDT - 3 months ago

Codexis Annual report: Q4 2025


Codexis Earnings release: Q4 2025

Mar 11, 2026, 4:30 PM EDT - 3 months ago

Codexis Earnings release: Q4 2025


Codexis reports Q4 EPS 11c, consensus (4c)

2026-03-11T20:25:25.000Z - 3 months ago

Codexis reports Q4 EPS 11c, consensus (4c)


Codexis sees FY26 revenue $72M-$76M, consensus $70.8M

2026-03-11T20:25:07.000Z - 3 months ago

Codexis sees FY26 revenue $72M-$76M, consensus $70.8M


Codexis announces agreement to manufacture 50 g siRNA

2026-03-04T15:11:46.000Z - 3 months ago

Codexis announces agreement to manufacture 50 g siRNA


Codexis Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 11:50 AM EST - 3 months ago

Codexis Transcript: TD Cowen 46th Annual Health Care Conference


Codexis achieves ISO 9001:2015 certification

2026-02-10T14:05:57.000Z - 4 months ago

Codexis achieves ISO 9001:2015 certification


Codexis Achieves ISO 9001:2015 Certification

Feb 10, 2026, 9:00 AM EST - 4 months ago

Codexis Achieves ISO 9001:2015 Certification


Codexis signs evaluation agreement with Axolabs

2026-01-07T14:12:08.000Z - 5 months ago

Codexis signs evaluation agreement with Axolabs


Codexis reports Q3 EPS (22c), consensus (13c)

2025-11-06T22:35:34.000Z - 8 months ago

Codexis reports Q3 EPS (22c), consensus (13c)


Codexis Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Codexis Earnings Call Transcript: Q3 2025


Codexis Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Codexis Quarterly report: Q3 2025


Codexis Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Codexis Earnings release: Q3 2025


Codexis Slides: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Codexis Slides: Q3 2025


Codexis, Nitto Denko Avecia enter evaluation agreement

2025-10-29T14:05:32.000Z - 8 months ago

Codexis, Nitto Denko Avecia enter evaluation agreement


Codexis Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 3:55 PM EDT - 10 months ago

Codexis Transcript: Cantor Global Healthcare Conference 2025


Codexis to Participate in Cantor Global Healthcare Conference

Aug 28, 2025, 9:00 AM EDT - 10 months ago

Codexis to Participate in Cantor Global Healthcare Conference


Codexis Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Codexis Earnings Call Transcript: Q2 2025


Codexis Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Codexis Quarterly report: Q2 2025


Codexis Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Codexis Earnings release: Q2 2025


Codexis Slides: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Codexis Slides: Q2 2025


Codexis Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:05 PM EDT - 11 months ago

Codexis Reports Second Quarter 2025 Financial Results


Codexis Transcript: Status Update

May 22, 2025, 8:00 AM EDT - 1 year ago

Codexis Transcript: Status Update


Codexis Press release: Status Update

May 22, 2025, 8:00 AM EDT - 1 year ago

Codexis Press release: Status Update


Codexis Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Codexis Earnings Call Transcript: Q1 2025


Codexis Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Codexis Quarterly report: Q1 2025


Codexis Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Codexis Earnings release: Q1 2025


Codexis Slides: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Codexis Slides: Q1 2025


Codexis reports Q1 EPS (25c), consensus (21c)

2025-05-14T20:16:47.000Z - 1 year ago

Codexis reports Q1 EPS (25c), consensus (21c)


Codexis sees FY25 revenue $64M-$68M, consensus $65.67M

2025-05-14T20:16:39.000Z - 1 year ago

Codexis sees FY25 revenue $64M-$68M, consensus $65.67M


Codexis Reports First Quarter 2025 Financial Results

May 14, 2025, 4:05 PM EDT - 1 year ago

Codexis Reports First Quarter 2025 Financial Results


Codexis Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Codexis Proxy statement: Proxy Filing


Codexis Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Codexis Proxy statement: Proxy Filing


Codexis appoints Cynthia Collins to board of directors

2025-04-01T11:21:28.000Z - 1 year ago

Codexis appoints Cynthia Collins to board of directors


Codexis Announces New Employment Inducement Grants

Mar 7, 2025, 4:05 PM EST - 1 year ago

Codexis Announces New Employment Inducement Grants


Codexis reports Q4 EPS (13c), consensus (2c)

2025-02-27T22:00:31.000Z - 1 year ago

Codexis reports Q4 EPS (13c), consensus (2c)


Codexis sees FY25 revenue $64M-$68M, consensus $66.61M

2025-02-27T22:00:23.000Z - 1 year ago

Codexis sees FY25 revenue $64M-$68M, consensus $66.61M


Codexis Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Codexis Earnings Call Transcript: Q4 2024


Codexis Annual report: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Codexis Annual report: Q4 2024


Codexis Earnings release: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Codexis Earnings release: Q4 2024


Codexis Slides: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Codexis Slides: Q4 2024


Codexis Appoints Christos Richards to Board of Directors

Jan 16, 2025, 4:05 PM EST - 1 year ago

Codexis Appoints Christos Richards to Board of Directors


Codexis Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 2:25 PM EST - 1 year ago

Codexis Transcript: Stifel 2024 Healthcare Conference


Codexis Transcript: Status Update

Nov 14, 2024, 4:30 PM EST - 1 year ago

Codexis Transcript: Status Update


Codexis Press release: Status Update

Nov 14, 2024, 4:30 PM EST - 1 year ago

Codexis Press release: Status Update


Codexis to Participate in Upcoming Healthcare Conferences

Nov 4, 2024, 4:05 PM EST - 1 year ago

Codexis to Participate in Upcoming Healthcare Conferences


Codexis Earnings Call Transcript: Q3 2024

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Codexis Earnings Call Transcript: Q3 2024


Codexis Quarterly report: Q3 2024

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Codexis Quarterly report: Q3 2024


Codexis Earnings release: Q3 2024

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Codexis Earnings release: Q3 2024


Codexis Slides: Q3 2024

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Codexis Slides: Q3 2024


Codexis Publishes FY2023 Sustainability Disclosures

Aug 15, 2024, 4:05 PM EDT - 2 years ago

Codexis Publishes FY2023 Sustainability Disclosures


Codexis Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Codexis Earnings Call Transcript: Q2 2024


Codexis Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Codexis Quarterly report: Q2 2024


Codexis Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Codexis Earnings release: Q2 2024


Codexis Slides: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Codexis Slides: Q2 2024


Codexis Transcript: Jefferies Global Healthcare Conference

Jun 5, 2024, 11:30 AM EDT - 2 years ago

Codexis Transcript: Jefferies Global Healthcare Conference


Codexis Earnings Call Transcript: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Codexis Earnings Call Transcript: Q1 2024


Codexis Quarterly report: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Codexis Quarterly report: Q1 2024


Codexis Earnings release: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Codexis Earnings release: Q1 2024


Codexis Slides: Q1 2024

May 2, 2024, 4:30 PM EDT - 2 years ago

Codexis Slides: Q1 2024


Codexis Registration statement: Registration Filing

May 2, 2024, 8:00 AM EDT - 2 years ago

Codexis Registration statement: Registration Filing


Codexis Proxy statement: Proxy Filing

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Codexis Proxy statement: Proxy Filing


Codexis Proxy statement: Proxy Filing

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Codexis Proxy statement: Proxy Filing


Codexis to Report First Quarter 2024 Financial Results on May 2

Apr 18, 2024, 4:05 PM EDT - 2 years ago

Codexis to Report First Quarter 2024 Financial Results on May 2


Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Apr 11, 2024, 7:05 AM EDT - 2 years ago

Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board


Codexis Earnings Call Transcript: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

Codexis Earnings Call Transcript: Q4 2023


Codexis Annual report: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

Codexis Annual report: Q4 2023


Codexis Earnings release: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

Codexis Earnings release: Q4 2023


Codexis Slides: Q4 2023

Feb 28, 2024, 4:30 PM EST - 2 years ago

Codexis Slides: Q4 2023


djohndjohn
djohndjohn Jun. 22 at 9:19 PM
$CDXS Stephen G. DillyDally😀, M.B.B.S., Ph.D. received 47,074,970 votes in favor,😁 6,891,598 votes withheld😁, and 20,771,912 broker non-votes. 6,891,598 votes withheld, That's about the same amount of shares that Opaleye(AKA Jimmy)owns. Jimmy don't like DillyDally. I'm begining to feel the same way
0 · Reply
galaxySky
galaxySky Jun. 22 at 8:50 PM
$CDXS surprised this is disconnected from xbi. Macro trends aren't affecting it, sus..
0 · Reply
djohndjohn
djohndjohn Jun. 22 at 4:42 PM
$CDXS Dilly and BoD are a bunch of Bozo's Gave themselves way too many options with an exercise price of $2.48. Basically saying the stock is worth $2.48. Better get off their duff's and add some value for the shareholders
0 · Reply
Fingerlickengood
Fingerlickengood Jun. 19 at 3:13 PM
I believe the writing is on the wall, $MRK completely owning $CDXS IP now makes complete sense!
2 · Reply
Fingerlickengood
Fingerlickengood Jun. 19 at 1:03 PM
$CDXS $MRK "Protillion’s Prot-MaP™ technology and Codexis’ ECO Synthesis® platform represent two complementary frontiers in biotherapeutic engineering: Prot-MaP focuses on ultra-high-throughput, AI-driven protein discovery and optimization, while ECO Synthesis focuses on scalable, green therapeutic RNA manufacturing. Together, they showcase the industry-wide shift toward integrating automated high-throughput biology, AI, and green biocatalysis to overcome traditional drug development bottlenecks. While Protillion’s primary focus is on protein/antibody design (amino acids) and Codexis' ECO platform is generally for RNA/oligonucleotides, the two technologies could intersect if a developer is working on complex conjugate therapies or if Codexis applies its enzyme technology to peptide/protein manufacturing."
4 · Reply
JulesRocketManVern
JulesRocketManVern Jun. 18 at 6:56 PM
$CDXS hit the break out..... Come on!
0 · Reply
Trq2507
Trq2507 Jun. 18 at 5:44 PM
$CDXS takeover @ $9.50
0 · Reply
Kanate123
Kanate123 Jun. 18 at 1:28 PM
$RUM $CDXS bet the ranch a trie lottery ticket
1 · Reply
Kanate123
Kanate123 Jun. 18 at 1:24 PM
$QS also buy Codexis $CDXS a triple from here check out cantor fitzgerald 11 price yesterday
2 · Reply
Kanate123
Kanate123 Jun. 18 at 1:20 PM
$QS this is another good runner, but I also own a ton of codexis .  I took a major position in yesterday Canter raised and reiterates an $11 stock price. This is at least a triple if not more. $CDXS  I bet the ranch big-time
0 · Reply
Kanate123
Kanate123 Jun. 18 at 1:16 PM
$RUM definitely number one Stock also buy $CDXS  this company is a lottery ticket with Canter Fitzgerald, putting $11 price target on it. This is a no-brainer also for a takeover.
0 · Reply
Kanate123
Kanate123 Jun. 18 at 1:07 PM
$VCX $CDXS - this is a triple stock here easily look what cooper said about it yesterday or a buyout easily take over target
0 · Reply
Kanate123
Kanate123 Jun. 18 at 1:04 PM
$RUMBW you also must own $CDXS  this is a lottery ticket where the stock will at least triple per Share look at Canter reiterating an $11 price target yesterday. This is a no-brainer. You’ve gotta buy it.
0 · Reply
Kanate123
Kanate123 Jun. 18 at 1:03 PM
$CAST $CDXS -both of these stocks are must owned  this is a lottery ticket and then no-brainer at least the triple on the stock.look at cantor fitzgeerald  they reiterated the price to $11
0 · Reply
Kanate123
Kanate123 Jun. 18 at 1:00 PM
$JBL you must also own codexis $CDXS - a buyout
0 · Reply
Kanate123
Kanate123 Jun. 18 at 12:59 PM
$RUM $CDXS - I love rum Stock, but I also like codexis . $CDXS  this is a lottery ticket and at least a triple look at Canter’s recommendation yesterday. $11.
0 · Reply
Kanate123
Kanate123 Jun. 18 at 12:54 PM
$RUM $CDXS if you dont buy codexis you’re a fool. this company is at least a triple canter put a $11 price target on it yesterday. Buy this lottery ticket today and leave it alone.
0 · Reply
Kanate123
Kanate123 Jun. 18 at 12:48 PM
$RUM I love rum, but you have to own codexis also .$CDXS
0 · Reply
Kanate123
Kanate123 Jun. 18 at 12:39 PM
$LPA - $CDXS this company codexis os a lottery ticket buy. a 11 price by cantor yesteesa a teiple at least takeover
0 · Reply
Kanate123
Kanate123 Jun. 18 at 12:37 PM
$CAST - $CDXS this stock is a lottery ticket buy it . cantor put a 11 price target . takeover
0 · Reply
Kanate123
Kanate123 Jun. 18 at 12:32 PM
$CAST $CDXS a lottery ticket a must buy
0 · Reply
Kanate123
Kanate123 Jun. 18 at 12:29 PM
$CAST - $CDXS - this company is a must own a triple at least cantor fitz just just said yesterday 11.00 u must own this lottery ticket
0 · Reply